Congo vs India: Treatment coverage for lymphatic filariasis
Congo
82.1%
in 2024
India
83.8%
in 2024
Congo rank
12th
India rank
9th
Treatment coverage for lymphatic filariasis over time
- Congo
- India
How they compare
India currently reports 83.8% against 82.1% in Congo, a difference of 1.7%.
The two have swapped places 2 times across 12 shared years of data; in 2013 it was India ahead.
Congo ranks 12th and India ranks 9th of 66 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.0% | 60.5% | 42.6% | India |
| 2020s | 54.4% | 55.8% | 1.4% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Congo or India?
- India, at 83.8% against 82.1% in Congo as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Congo and India?
- 1.7%, with India ahead.
- How many years of comparable data are there for Congo and India?
- 12 years are reported by both, from 2013 to 2024.
- How do Congo and India rank globally for treatment coverage for lymphatic filariasis?
- Congo ranks 12th and India ranks 9th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.